2021. Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy. Farmeconomia. Health Economics and Therapeutic Pathways. 22, 1 (Jun. 2021). DOI:https://doi.org/10.7175/fe.v22i1.1499.